Laurus Labs

BSE : 540222 | NSE : LAURUSLABS

Industry : Pharma Formulations | ISIN : INE947Q01028 | FreeFloat : 30.00% | FnO : Yes | LotSize : 900


Intellectual Capital (IC)12,230.86
Net Worth (NW)3,004.98
Intrinsic Worth (IW)15,235.84
Market Cap (MC)33,078.86
Economic Value Added71.24
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)80.28%
IC Gross Margin (EBITDA/IC)10.82%
IC Net Margin (NPT/IC)6.46%
Knowledge Turnover (Sales/IC)0.36
Market to Intrinsic Value (MC/IW)2.17

As OfIntrinsic ValueMarket Price
30 Sep 2021Rs. 283.93Rs. 616.45
6 Dec 2021 ---- Rs. 501.95
-9.45     -1.88%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 509.76SellAvoid
KB > 50% : Yes50 DMA : Rs. 551.86
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Dec-18
C
529.46
530.87
89.13
46.42
22.77
17.82
20.26
Mar-19
C
635.16
636.78
113.61
70.14
52.57
43.18
44.11
Jun-19
C
550.57
555.07
87.76
41.92
19.39
15.10
15.73
Sep-19
C
712.42
713.78
139.17
91.34
65.77
56.55
56.44
Dec-19
C
729.59
731.51
150.10
102.55
81.71
73.48
73.58
Mar-20
C
839.14
840.82
193.45
147.40
126.74
110.15
98.15
Jun-20
C
974.32
981.41
285.41
236.61
221.47
171.78
172.51
Sep-20
C
1138.84
1143.96
378.99
327.99
314.31
242.27
250.54
Dec-20
C
1288.42
1295.35
433.23
381.59
364.16
272.85
274.18
Mar-21
C
1411.93
1416.45
476.71
423.08
401.17
296.92
296.82
Jun-21
C
1278.50
1284.35
401.20
342.66
316.05
241.61
241.07
Sep-21
C
1203.48
1206.31
347.91
284.72
262.59
203.95
203.29
* C - Consolidated, S - Standalone